Loomis Sayles & Co. L P lifted its stake in shares of The Procter & Gamble Company (NYSE:PG – Free Report) by 3.5% in the 3rd quarter, HoldingsChannel.com reports. The fund owned 61,664 shares of the company’s stock after acquiring an additional 2,112 shares during the period. Loomis Sayles & Co. L P’s holdings in Procter & Gamble were worth $10,680,000 as of its most recent SEC filing.
A number of other hedge funds have also made changes to their positions in the stock. DRW Securities LLC boosted its position in Procter & Gamble by 33.0% during the third quarter. DRW Securities LLC now owns 19,335 shares of the company’s stock worth $3,349,000 after purchasing an additional 4,793 shares during the period. Independent Advisor Alliance lifted its stake in shares of Procter & Gamble by 3.3% in the third quarter. Independent Advisor Alliance now owns 136,050 shares of the company’s stock worth $23,564,000 after buying an additional 4,301 shares during the last quarter. Harvest Fund Management Co. Ltd boosted its holdings in shares of Procter & Gamble by 218.9% during the 3rd quarter. Harvest Fund Management Co. Ltd now owns 5,124 shares of the company’s stock worth $887,000 after buying an additional 3,517 shares during the period. Dynamic Technology Lab Private Ltd grew its stake in Procter & Gamble by 33.8% in the 3rd quarter. Dynamic Technology Lab Private Ltd now owns 20,127 shares of the company’s stock valued at $3,486,000 after buying an additional 5,088 shares during the last quarter. Finally, Davis R M Inc. raised its holdings in Procter & Gamble by 10.9% in the 3rd quarter. Davis R M Inc. now owns 248,442 shares of the company’s stock worth $43,030,000 after acquiring an additional 24,489 shares during the period. Institutional investors and hedge funds own 65.77% of the company’s stock.
Insider Activity
In related news, insider Balaji Purushothaman sold 12,800 shares of Procter & Gamble stock in a transaction dated Thursday, November 21st. The stock was sold at an average price of $172.73, for a total value of $2,210,944.00. Following the completion of the transaction, the insider now directly owns 11,595 shares of the company’s stock, valued at $2,002,804.35. The trade was a 52.47 % decrease in their ownership of the stock. The transaction was disclosed in a filing with the SEC, which is available through the SEC website. Also, insider Susan Street Whaley sold 634 shares of the stock in a transaction dated Wednesday, October 2nd. The stock was sold at an average price of $171.65, for a total transaction of $108,826.10. Following the sale, the insider now directly owns 19,341 shares in the company, valued at approximately $3,319,882.65. This represents a 3.17 % decrease in their position. The disclosure for this sale can be found here. Over the last 90 days, insiders sold 35,233 shares of company stock worth $6,024,234. Insiders own 0.18% of the company’s stock.
Procter & Gamble Price Performance
Procter & Gamble (NYSE:PG – Get Free Report) last issued its earnings results on Friday, October 18th. The company reported $1.93 EPS for the quarter, beating the consensus estimate of $1.90 by $0.03. The company had revenue of $21.74 billion for the quarter, compared to the consensus estimate of $21.99 billion. Procter & Gamble had a net margin of 17.07% and a return on equity of 33.25%. The firm’s revenue for the quarter was down .6% compared to the same quarter last year. During the same quarter in the previous year, the company earned $1.83 EPS. On average, sell-side analysts forecast that The Procter & Gamble Company will post 6.96 EPS for the current fiscal year.
Procter & Gamble Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, November 15th. Stockholders of record on Friday, October 18th were issued a dividend of $1.0065 per share. This represents a $4.03 annualized dividend and a dividend yield of 2.24%. The ex-dividend date of this dividend was Friday, October 18th. Procter & Gamble’s payout ratio is 69.48%.
Analyst Ratings Changes
A number of equities research analysts have issued reports on the stock. Evercore ISI raised their price target on Procter & Gamble from $180.00 to $183.00 and gave the company an “outperform” rating in a research report on Monday, October 21st. DZ Bank raised Procter & Gamble from a “hold” rating to a “buy” rating and set a $190.00 target price on the stock in a report on Thursday, August 29th. StockNews.com lowered Procter & Gamble from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Hsbc Global Res raised shares of Procter & Gamble to a “strong-buy” rating in a research report on Friday, October 4th. Finally, Piper Sandler started coverage on shares of Procter & Gamble in a research note on Tuesday, September 24th. They set a “neutral” rating and a $174.00 target price for the company. Eight analysts have rated the stock with a hold rating, fourteen have issued a buy rating and two have assigned a strong buy rating to the company’s stock. Based on data from MarketBeat.com, Procter & Gamble has an average rating of “Moderate Buy” and a consensus target price of $180.45.
Check Out Our Latest Research Report on PG
Procter & Gamble Profile
The Procter & Gamble Company engages in the provision of branded consumer packaged goods worldwide. The company operates through five segments: Beauty; Grooming; Health Care; Fabric & Home Care; and Baby, Feminine & Family Care. The Beauty segment offers conditioners, shampoos, styling aids, and treatments under the Head & Shoulders, Herbal Essences, Pantene, and Rejoice brands; and antiperspirants and deodorants, personal cleansing, and skin care products under the Olay, Old Spice, Safeguard, Secret, SK-II, and Native brands.
Featured Stories
- Five stocks we like better than Procter & Gamble
- High Flyers: 3 Natural Gas Stocks for March 2022
- Microsoft Stock Gets a $550 Price Target: Time to Get Excited
- How to Calculate Return on Investment (ROI)
- Trump Tariffs in Focus: 2 Chinese Stocks to Own and 2 to Avoid
- Biggest Stock Losers – Today’s Biggest Percentage Decliners
- 2 Generic Drug Stocks Ready to Surge in 2025
Want to see what other hedge funds are holding PG? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for The Procter & Gamble Company (NYSE:PG – Free Report).
Receive News & Ratings for Procter & Gamble Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Procter & Gamble and related companies with MarketBeat.com's FREE daily email newsletter.